![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 401/04 | (2006.01) |
C07D 403/04 | (2006.01) | ||
A61K 31/4184 | (2006.01) | ||
A61K 31/454 | (2006.01) |
(11) | Number of the document | 1869011 |
(13) | Kind of document | T |
(96) | European patent application number | 06749882.4 |
Date of filing the European patent application | 2006-04-11 | |
(97) | Date of publication of the European application | 2007-12-26 |
(45) | Date of publication and mention of the grant of the patent | 2012-08-01 |
(46) | Date of publication of the claims translation | 2012-11-26 |
(86) | Number | PCT/US2006/013652 |
Date | 2006-04-11 |
(87) | Number | WO 2006/110816 |
Date | 2006-10-19 |
(30) | Number | Date | Country code |
670204 P | 2005-04-11 | US |
(72) |
ZHU, Guidong, US
GONG, Jianchun, US
GANDHI, Virajkumar, B., US
PENNING, Thomas, D., US
GIRANDA, Vincent, US
|
(73) |
AbbVie Ireland Unlimited Company,
c/o Codan Services Limited, Clarendon House, 2 Church Street, HM11 Hamilton,
BM
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | 1H-benzimidazol-4-karboksamidai, pakeisti ketvirtine anglimi 2 padėtyje, yra stipriai veikiantys PARP inhibitoriai |
1H-BENZIMIDAZOLE-4-CARBOXAMIDES SUBSTITUTED WITH A QUATERNARY CARBON AT THE 2-POSITION ARE POTENT PARP INHIBITORS |
Payment date | Validity (years) | Amount | |
2024-03-18 | 19 | 347.00 EUR |
2025-04-11 |